TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Financial Statements and ExhibitsItem 9.01
Tonix Pharmaceuticals Holding Corp. ExhibitEX-99.01 2 s111370_ex99-01.htm EXHIBIT 99.01 Exhibit 99.01 Tonix Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for TNX-102 SL for Treatment of Agitation in Alzheimer’s Disease NEW YORK,…To view the full exhibit click here